Raia Drogasil S.A Market Cap ($5.22 Billion)
Market Cap & Net Worth: Raia Drogasil S.A (RADL3)
Raia Drogasil S.A market cap. Raia Drogasil S.A (SA:RADL3) has a market capitalization of $5.22 Billion (R$26.61 Billion) as of November 1, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #3350 globally and #42 in its home market, demonstrating a -25.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Raia Drogasil S.A's stock price R$15.22 by its total outstanding shares 1748536237 (1.75 Billion). Also see Raia Drogasil S.A (RADL3) cash conversion ratio for how efficiently the company converts equity into cash flow.
Raia Drogasil S.A Market Cap History (2015–2026)
Raia Drogasil S.A market cap history from 2015 to 2026. Data shows growth from $2.15 Billion to $5.22 Billion (7.06% CAGR). Check Raia Drogasil S.A stock quote for real-time trading data and today's change.
Index Memberships
Raia Drogasil S.A is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BOVESPA Index
BVSP
|
$560.42 Billion | 0.93% | #27 of 80 |
|
Bovespa Brazil 50
IBX50
|
$477.09 Billion | 1.09% | #20 of 50 |
|
SAO PAULO SE IBX50 INDEX
IBXL
|
$458.84 Billion | 1.14% | #20 of 50 |
|
SAO PAULO SE IGCX INDEX
IGCX
|
$575.58 Billion | 0.91% | #27 of 155 |
|
IVBX IND
IVBX
|
$197.30 Billion | 2.65% | #15 of 45 |
Weight: Raia Drogasil S.A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Raia Drogasil S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Raia Drogasil S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Raia Drogasil S.A net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
Raia Drogasil S.A's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.20x
Raia Drogasil S.A's market cap is 6.20 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.75 Billion | $11.26 Billion | $447.69 Million | 0.33x | 8.38x |
| 2017 | $5.68 Billion | $13.21 Billion | $511.16 Million | 0.43x | 11.10x |
| 2018 | $3.57 Billion | $14.80 Billion | $502.45 Million | 0.24x | 7.10x |
| 2019 | $7.03 Billion | $17.57 Billion | $772.24 Million | 0.40x | 9.10x |
| 2020 | $7.93 Billion | $20.07 Billion | $484.44 Million | 0.40x | 16.36x |
| 2021 | $7.77 Billion | $24.13 Billion | $751.93 Million | 0.32x | 10.33x |
| 2022 | $7.67 Billion | $29.07 Billion | $996.11 Million | 0.26x | 7.70x |
| 2023 | $9.98 Billion | $33.97 Billion | $1.05 Billion | 0.29x | 9.46x |
| 2024 | $7.55 Billion | $38.86 Billion | $1.20 Billion | 0.19x | 6.30x |
| 2025 | $8.05 Billion | $44.25 Billion | $1.30 Billion | 0.18x | 6.20x |
Competitor Companies of RADL3 by Market Capitalization
Companies near Raia Drogasil S.A in the global market cap rankings as of November 1, 2026. Also see total assets of Raia Drogasil S.A for a full breakdown of the balance sheet.
Key companies related to Raia Drogasil S.A by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1867 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2108 globally with a market cap of $10.37 Billion USD.
- Yifeng Pharmacy (SHG:603939): Ranked #3595 globally with a market cap of $4.69 Billion USD ( CN¥32.08 Billion CNY).
- Dashenlin Pharm Grp Co Ltd (SHG:603233): Ranked #4418 globally with a market cap of $3.38 Billion USD ( CN¥23.07 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1867 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.30 |
| #2108 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #3595 | Yifeng Pharmacy | SHG:603939 | $4.69 Billion | CN¥26.46 |
| #4418 | Dashenlin Pharm Grp Co Ltd | SHG:603233 | $3.38 Billion | CN¥20.26 |
Market Capitalization of Raia Drogasil S.A (2015–2026)
Market capitalization of Raia Drogasil S.A from 2015 to today. Between 2015 and today, Raia Drogasil S.A's market cap moved from $2.15 Billion to $ 5.22 Billion, with a yearly change of 7.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$5.22 Billion | -35.10% |
| 2025 | R$8.05 Billion | +6.59% |
| 2024 | R$7.55 Billion | -24.38% |
| 2023 | R$9.98 Billion | +30.14% |
| 2022 | R$7.67 Billion | -1.25% |
| 2021 | R$7.77 Billion | -2.01% |
| 2020 | R$7.93 Billion | +12.81% |
| 2019 | R$7.03 Billion | +96.97% |
| 2018 | R$3.57 Billion | -37.15% |
| 2017 | R$5.68 Billion | +51.38% |
| 2016 | R$3.75 Billion | +74.27% |
| 2015 | R$2.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Raia Drogasil S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.22 Billion USD |
| MoneyControl | $5.22 Billion USD |
| MarketWatch | $5.22 Billion USD |
| marketcap.company | $5.22 Billion USD |
| Reuters | $5.22 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Raia Drogasil S.A
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.